Key result
CXCR3 deficiency impairs postischemic neovascularization and reduces VEGF protein levels by ~80%.
Answers are grounded in this paper and cite their sources.
Inflammatory cell infiltration is a feature of postischemic neovascularization. However, mechanisms leading to leukocyte attraction to the site of neovascularization are still undefined. We hypothesized that the CXC chemokine receptor 3 (CXCR3) may contribute to leukocyte accumulation and subsequently to blood vessel growth in the ischemic area. Ischemia induced by femoral artery ligature improved the number of CXCR3-expressing cells and the level of its ligand, CXCL10. Angiographic score, blood flow recovery measurement, and capillary density analysis showed a significant decrease of ischemic/nonischemic leg ratio in CXCR3-deficient mice when compared with controls (P<0.05), at day 21 after ischemia. Interestingly, this impairment was as important as that observed in mice deficient for the well known CC-chemokine monocyte chemoattractant protein-1 (MCP-1). At day 7 of ischemic injury, the number of CD3-positive T cells and Mac-3-positive monocytes/macrophages was 38% and 45% lower, respectively, in the ischemic leg of CXCR3-deficient mice compared with the control group (P<0.05), suggesting an important role for CXCR3 in leukocyte recruitment into the ischemic area. VEGF protein content, a classical proangiogenic factor, was also markedly reduced (80% reduction) in ischemic leg of CXCR3-deficient mice (P<0.01). Injection of bone marrow-derived mononuclear cells (BM-MNCs) isolated from wild-type animals restored the neovascularization reaction in CXCR3-deficient mice whereas BM-MNCs from CXCR3-deficient mice was ineffective. In conclusion, CXCR3 plays a key role in neovascularization and provides novel information on the mechanisms leading to leukocyte infiltration in the vessel growth area.
No takes yet. Share an insight, caveat, or question.
Waeckel et al. (2005) studied Hindlimb ischemia (femoral artery ligature in mice). CXCR3 deficiency (and injection of bone marrow-derived mononuclear cells) vs. Wild-type control mice was evaluated on Postischemic neovascularization (angiographic score, blood flow recovery, and capillary density ischemic/nonischemic leg ratio at day 21) (p=<0.05). CXCR3 deficiency in mice decreased postischemic neovascularization and reduced VEGF protein content by 80% compared with wild-type controls.
Synapse has enriched 10 related papers. Consider them for comparative context: